ESC 365 - Association between immune checkpoint inhibitors and vascular endothelial growth factor targeted therapy with cardiovascular events

ESC Professional Premium Access

Association between immune checkpoint inhibitors and vascular endothelial growth factor targeted therapy with cardiovascular events

Session: Cardio-oncology 3

Topic: Cardio-Oncology

Speaker: Doctor Z. Drobni (Budapest, HU)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Zsofia Dora Drobni

Semmelweis University, Budapest (Hungary)

1 presentation

0 follower

7 more presentations in this session

Low-dose anticoagulation for peripheral deep vein thrombosis of the lower extremities in cancer patients

Speaker: Doctor A. Nonaka (Akashi, JP)

Cardiorespiratory fitness and left ventricular function in breast cancer survivors a decade after Epirubicin treatment

Speaker: Miss M. Saeter (Oslo, NO)

Cancer as a risk factor for physical dysfunction and poor prognosis in patients with cardiovascular disease

Speaker: Mr T. Miki (Sagamihara, JP)

Five-year cardiovascular outcomes in patients with chronic myeloid leukemia treated with imatinib, dasatinib or nilotinib: data from a large multinational collaborative network

Speaker: Doctor R. Belo Nunes (Sao Paulo, BR)

Coronary calcification is independently associated with major adverse cardiovascular events in men with recurrent prostate cancer while aortic calcification is not

Speaker: Doctor A. Som (Saint Louis, US)

Access the full session

Cardio-oncology 3

Speakers: Doctor Z. Drobni, Doctor A. Nonaka, Miss M. Saeter, Mr T. Miki, Doctor R. Belo Nunes...

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources